PIVOT POINTS for resistance and support of a particular stock: Keep in mind that pivot points are short-term, over-night trend indicators, useful for only one day at a time. They need to be recalculated every day using the changing price movement. When you are coming in with a bunch of calls, you need to study the historical data for each stock, determin the direction of … [Read more...]
NSE Certified Market Professional (NCMP)
NSMP is “NSE Certified Market Professional (NCMP)” .NSE has started offering this certificates to those who have cleared NCFM modules from August 17, 2009, as per the following eligibility criteria: * NCMP Level 1 : 3 – 4 modules * NCMP Level 2 : 5 – 6 modules * NCMP Level 3 : 7 – 8 modules * NCMP Level 4 : 9 or more modules Here is the list of the modules qualifying … [Read more...]
National Institute of Securities Markets (NISM)
National Institute of Securities Markets (NISM) is a public trust, established by the Securities and Exchange Board of India (SEBI), the regulator for securities markets in India. It is located in Navi Mumbai, India. NISM seeks to add to market quality through educational initiatives. It is an autonomous body governed by its Board of Governors. An international Advisory … [Read more...]
Stock Update ; UltraTech Cement
UltraTech Cement Cluster: Ugly Duckling Recommendation: Buy Price target: Rs940 Current market price: Rs740 UltraTech-Samruddhi merger; swap ratio 4:7 Key points The boards of directors of UltraTech Cement (UltraTech) and Samruddhi Cement (Samruddhi), a wholly owned subsidiary of Grasim Industries (Grasim), have approved Samruddhi?s merger with UltraTech. The … [Read more...]
STOCK UPDATE;Glenmark Pharmaceuticals
Glenmark Pharmaceuticals Cluster: Apple Green Recommendation: Buy Price target: Rs285 Current market price: Rs230 Glenmark announces some positive deals with Medicis Glenmark Pharmaceuticals (Glenmark) has made a series of announcements regarding its patent settlement (Vanos), abbreviated new drug application (ANDA) approval (Ciclopirox) and outlicencing deal (a specialty … [Read more...]